nodes	percent_of_prediction	percent_of_DWPC	metapath
Asenapine—CYP1A2—Carmustine—malignant glioma	0.133	0.569	CbGbCtD
Asenapine—CYP3A4—Temozolomide—malignant glioma	0.101	0.43	CbGbCtD
Asenapine—HTR1D—meninx—malignant glioma	0.031	0.086	CbGeAlD
Asenapine—HTR1B—dura mater—malignant glioma	0.0295	0.0817	CbGeAlD
Asenapine—HTR1D—dura mater—malignant glioma	0.0286	0.0791	CbGeAlD
Asenapine—HTR2C—choroid plexus—malignant glioma	0.024	0.0666	CbGeAlD
Asenapine—DRD3—telencephalic ventricle—malignant glioma	0.0127	0.0351	CbGeAlD
Asenapine—HTR2A—choroid plexus—malignant glioma	0.0121	0.0334	CbGeAlD
Asenapine—DRD1—telencephalic ventricle—malignant glioma	0.00907	0.0251	CbGeAlD
Asenapine—Traumatic liver injury—Temozolomide—malignant glioma	0.00812	0.0578	CcSEcCtD
Asenapine—HTR1B—telencephalic ventricle—malignant glioma	0.00735	0.0204	CbGeAlD
Asenapine—HTR1D—telencephalic ventricle—malignant glioma	0.00711	0.0197	CbGeAlD
Asenapine—HTR2C—telencephalic ventricle—malignant glioma	0.00704	0.0195	CbGeAlD
Asenapine—HTR7—pons—malignant glioma	0.00689	0.0191	CbGeAlD
Asenapine—HTR2A—cerebellar cortex—malignant glioma	0.00607	0.0168	CbGeAlD
Asenapine—HTR1A—telencephalic ventricle—malignant glioma	0.00593	0.0164	CbGeAlD
Asenapine—HTR7—telencephalic ventricle—malignant glioma	0.00567	0.0157	CbGeAlD
Asenapine—DRD2—telencephalic ventricle—malignant glioma	0.00536	0.0148	CbGeAlD
Asenapine—HTR5A—central nervous system—malignant glioma	0.00497	0.0138	CbGeAlD
Asenapine—HTR2A—pons—malignant glioma	0.00429	0.0119	CbGeAlD
Asenapine—HTR2A—vertebral column—malignant glioma	0.00426	0.0118	CbGeAlD
Asenapine—HTR1E—brainstem—malignant glioma	0.0042	0.0116	CbGeAlD
Asenapine—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00402	0.0286	CcSEcCtD
Asenapine—HTR5A—brain—malignant glioma	0.00394	0.0109	CbGeAlD
Asenapine—HTR1E—telencephalon—malignant glioma	0.00373	0.0103	CbGeAlD
Asenapine—HTR1B—blood vessel—malignant glioma	0.00364	0.0101	CbGeAlD
Asenapine—Liver injury—Temozolomide—malignant glioma	0.00359	0.0256	CcSEcCtD
Asenapine—HTR2A—telencephalic ventricle—malignant glioma	0.00353	0.00979	CbGeAlD
Asenapine—HTR1D—blood vessel—malignant glioma	0.00352	0.00976	CbGeAlD
Asenapine—Amenorrhoea—Temozolomide—malignant glioma	0.00344	0.0245	CcSEcCtD
Asenapine—Pulmonary embolism—Carmustine—malignant glioma	0.00313	0.0223	CcSEcCtD
Asenapine—HTR2A—pineal body—malignant glioma	0.00307	0.00849	CbGeAlD
Asenapine—HTR7—endothelium—malignant glioma	0.00304	0.00843	CbGeAlD
Asenapine—Pulmonary embolism—Temozolomide—malignant glioma	0.00303	0.0215	CcSEcCtD
Asenapine—Skin exfoliation—Carmustine—malignant glioma	0.00299	0.0213	CcSEcCtD
Asenapine—HTR6—telencephalon—malignant glioma	0.00293	0.00811	CbGeAlD
Asenapine—Skin exfoliation—Temozolomide—malignant glioma	0.00289	0.0205	CcSEcCtD
Asenapine—HTR7—blood vessel—malignant glioma	0.0028	0.00777	CbGeAlD
Asenapine—Gynaecomastia—Carmustine—malignant glioma	0.0028	0.0199	CcSEcCtD
Asenapine—Diabetes mellitus—Carmustine—malignant glioma	0.00261	0.0186	CcSEcCtD
Asenapine—Swelling—Carmustine—malignant glioma	0.00258	0.0183	CcSEcCtD
Asenapine—DRD1—brainstem—malignant glioma	0.00245	0.0068	CbGeAlD
Asenapine—Hyponatraemia—Carmustine—malignant glioma	0.00228	0.0162	CcSEcCtD
Asenapine—DRD1—telencephalon—malignant glioma	0.00218	0.00603	CbGeAlD
Asenapine—HTR1E—central nervous system—malignant glioma	0.00212	0.00588	CbGeAlD
Asenapine—HTR1B—brainstem—malignant glioma	0.00199	0.00551	CbGeAlD
Asenapine—Breast disorder—Temozolomide—malignant glioma	0.00198	0.0141	CcSEcCtD
Asenapine—Dysphagia—Carmustine—malignant glioma	0.00196	0.014	CcSEcCtD
Asenapine—DRD4—brain—malignant glioma	0.00195	0.00541	CbGeAlD
Asenapine—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00194	0.0138	CcSEcCtD
Asenapine—HTR1D—brainstem—malignant glioma	0.00192	0.00533	CbGeAlD
Asenapine—HTR2C—brainstem—malignant glioma	0.00191	0.00528	CbGeAlD
Asenapine—Dysphagia—Temozolomide—malignant glioma	0.0019	0.0135	CcSEcCtD
Asenapine—HTR2A—endothelium—malignant glioma	0.0019	0.00526	CbGeAlD
Asenapine—Neutropenia—Carmustine—malignant glioma	0.00184	0.0131	CcSEcCtD
Asenapine—SLC6A4—brainstem—malignant glioma	0.00181	0.00501	CbGeAlD
Asenapine—Neutropenia—Temozolomide—malignant glioma	0.00177	0.0126	CcSEcCtD
Asenapine—Hyperglycaemia—Carmustine—malignant glioma	0.00177	0.0126	CcSEcCtD
Asenapine—HTR1B—telencephalon—malignant glioma	0.00176	0.00489	CbGeAlD
Asenapine—HTR2A—blood vessel—malignant glioma	0.00175	0.00485	CbGeAlD
Asenapine—Depression—Carmustine—malignant glioma	0.00175	0.0124	CcSEcCtD
Asenapine—DRD3—central nervous system—malignant glioma	0.00173	0.00479	CbGeAlD
Asenapine—Weight increased—Temozolomide—malignant glioma	0.00173	0.0123	CcSEcCtD
Asenapine—Hyperglycaemia—Temozolomide—malignant glioma	0.00171	0.0122	CcSEcCtD
Asenapine—HTR1D—telencephalon—malignant glioma	0.00171	0.00473	CbGeAlD
Asenapine—Stomatitis—Carmustine—malignant glioma	0.00171	0.0121	CcSEcCtD
Asenapine—HTR2C—telencephalon—malignant glioma	0.00169	0.00469	CbGeAlD
Asenapine—Depression—Temozolomide—malignant glioma	0.00169	0.012	CcSEcCtD
Asenapine—HTR1E—brain—malignant glioma	0.00168	0.00466	CbGeAlD
Asenapine—Amoxapine—SLC6A3—malignant glioma	0.00167	0.562	CrCbGaD
Asenapine—HTR6—central nervous system—malignant glioma	0.00166	0.00461	CbGeAlD
Asenapine—ADRB1—telencephalon—malignant glioma	0.00166	0.0046	CbGeAlD
Asenapine—Stomatitis—Temozolomide—malignant glioma	0.00165	0.0117	CcSEcCtD
Asenapine—HTR1A—brainstem—malignant glioma	0.0016	0.00445	CbGeAlD
Asenapine—SLC6A4—telencephalon—malignant glioma	0.0016	0.00444	CbGeAlD
Asenapine—Hepatobiliary disease—Temozolomide—malignant glioma	0.0016	0.0114	CcSEcCtD
Asenapine—HTR2B—telencephalon—malignant glioma	0.00159	0.0044	CbGeAlD
Asenapine—DRD1—midbrain—malignant glioma	0.00156	0.00433	CbGeAlD
Asenapine—Oedema peripheral—Carmustine—malignant glioma	0.00155	0.011	CcSEcCtD
Asenapine—Connective tissue disorder—Carmustine—malignant glioma	0.00154	0.011	CcSEcCtD
Asenapine—HTR7—brainstem—malignant glioma	0.00153	0.00425	CbGeAlD
Asenapine—HRH2—central nervous system—malignant glioma	0.00152	0.00422	CbGeAlD
Asenapine—Oedema peripheral—Temozolomide—malignant glioma	0.0015	0.0106	CcSEcCtD
Asenapine—Connective tissue disorder—Temozolomide—malignant glioma	0.00149	0.0106	CcSEcCtD
Asenapine—ADRA1A—brainstem—malignant glioma	0.00148	0.0041	CbGeAlD
Asenapine—Eye disorder—Carmustine—malignant glioma	0.00147	0.0104	CcSEcCtD
Asenapine—DRD2—brainstem—malignant glioma	0.00145	0.00402	CbGeAlD
Asenapine—HTR1A—telencephalon—malignant glioma	0.00142	0.00395	CbGeAlD
Asenapine—Eye disorder—Temozolomide—malignant glioma	0.00142	0.0101	CcSEcCtD
Asenapine—Cardiac disorder—Temozolomide—malignant glioma	0.00141	0.01	CcSEcCtD
Asenapine—DRD2—retina—malignant glioma	0.0014	0.00388	CbGeAlD
Asenapine—Angiopathy—Temozolomide—malignant glioma	0.00138	0.0098	CcSEcCtD
Asenapine—Mental disorder—Carmustine—malignant glioma	0.00138	0.0098	CcSEcCtD
Asenapine—Immune system disorder—Temozolomide—malignant glioma	0.00137	0.00976	CcSEcCtD
Asenapine—DRD3—brain—malignant glioma	0.00137	0.0038	CbGeAlD
Asenapine—Mediastinal disorder—Temozolomide—malignant glioma	0.00137	0.00974	CcSEcCtD
Asenapine—Malnutrition—Carmustine—malignant glioma	0.00137	0.00973	CcSEcCtD
Asenapine—HTR7—telencephalon—malignant glioma	0.00136	0.00377	CbGeAlD
Asenapine—Mental disorder—Temozolomide—malignant glioma	0.00133	0.00947	CcSEcCtD
Asenapine—HTR2C—medulla oblongata—malignant glioma	0.00133	0.00368	CbGeAlD
Asenapine—Malnutrition—Temozolomide—malignant glioma	0.00132	0.00941	CcSEcCtD
Asenapine—HTR6—brain—malignant glioma	0.00132	0.00366	CbGeAlD
Asenapine—ADRA1A—telencephalon—malignant glioma	0.00131	0.00364	CbGeAlD
Asenapine—Loxapine—SLC6A3—malignant glioma	0.0013	0.439	CrCbGaD
Asenapine—Dysgeusia—Temozolomide—malignant glioma	0.00129	0.00921	CcSEcCtD
Asenapine—DRD2—telencephalon—malignant glioma	0.00129	0.00356	CbGeAlD
Asenapine—Tremor—Carmustine—malignant glioma	0.00128	0.00912	CcSEcCtD
Asenapine—HTR1B—midbrain—malignant glioma	0.00127	0.00351	CbGeAlD
Asenapine—Anaemia—Carmustine—malignant glioma	0.00126	0.009	CcSEcCtD
Asenapine—Agitation—Carmustine—malignant glioma	0.00126	0.00894	CcSEcCtD
Asenapine—ADRA2C—telencephalon—malignant glioma	0.00125	0.00347	CbGeAlD
Asenapine—Tremor—Temozolomide—malignant glioma	0.00124	0.00881	CcSEcCtD
Asenapine—DRD1—central nervous system—malignant glioma	0.00124	0.00343	CbGeAlD
Asenapine—HTR1B—spinal cord—malignant glioma	0.00124	0.00343	CbGeAlD
Asenapine—HTR1D—midbrain—malignant glioma	0.00123	0.0034	CbGeAlD
Asenapine—Leukopenia—Carmustine—malignant glioma	0.00122	0.00871	CcSEcCtD
Asenapine—Anaemia—Temozolomide—malignant glioma	0.00122	0.00869	CcSEcCtD
Asenapine—Agitation—Temozolomide—malignant glioma	0.00122	0.00864	CcSEcCtD
Asenapine—HTR2C—midbrain—malignant glioma	0.00121	0.00337	CbGeAlD
Asenapine—Angioedema—Temozolomide—malignant glioma	0.00121	0.00859	CcSEcCtD
Asenapine—HRH2—brain—malignant glioma	0.00121	0.00335	CbGeAlD
Asenapine—Malaise—Temozolomide—malignant glioma	0.00119	0.00848	CcSEcCtD
Asenapine—Convulsion—Carmustine—malignant glioma	0.00119	0.00843	CcSEcCtD
Asenapine—HTR2C—spinal cord—malignant glioma	0.00118	0.00328	CbGeAlD
Asenapine—Leukopenia—Temozolomide—malignant glioma	0.00118	0.00842	CcSEcCtD
Asenapine—Hypertension—Carmustine—malignant glioma	0.00118	0.0084	CcSEcCtD
Asenapine—Anxiety—Carmustine—malignant glioma	0.00116	0.00826	CcSEcCtD
Asenapine—SLC6A4—midbrain—malignant glioma	0.00115	0.00319	CbGeAlD
Asenapine—Convulsion—Temozolomide—malignant glioma	0.00115	0.00815	CcSEcCtD
Asenapine—Hypertension—Temozolomide—malignant glioma	0.00114	0.00812	CcSEcCtD
Asenapine—Arthralgia—Temozolomide—malignant glioma	0.00113	0.00801	CcSEcCtD
Asenapine—SLC6A4—spinal cord—malignant glioma	0.00112	0.00311	CbGeAlD
Asenapine—Anxiety—Temozolomide—malignant glioma	0.00112	0.00798	CcSEcCtD
Asenapine—Dry mouth—Temozolomide—malignant glioma	0.0011	0.00783	CcSEcCtD
Asenapine—Thrombocytopenia—Carmustine—malignant glioma	0.00109	0.00778	CcSEcCtD
Asenapine—Tachycardia—Carmustine—malignant glioma	0.00109	0.00775	CcSEcCtD
Asenapine—Anaphylactic shock—Temozolomide—malignant glioma	0.00108	0.00768	CcSEcCtD
Asenapine—HTR7—medulla oblongata—malignant glioma	0.00107	0.00296	CbGeAlD
Asenapine—Nervous system disorder—Temozolomide—malignant glioma	0.00106	0.00753	CcSEcCtD
Asenapine—Thrombocytopenia—Temozolomide—malignant glioma	0.00106	0.00752	CcSEcCtD
Asenapine—Hypotension—Carmustine—malignant glioma	0.00104	0.00742	CcSEcCtD
Asenapine—HTR2A—embryo—malignant glioma	0.00104	0.00289	CbGeAlD
Asenapine—HTR1A—midbrain—malignant glioma	0.00102	0.00283	CbGeAlD
Asenapine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00102	0.00724	CcSEcCtD
Asenapine—HRH1—telencephalon—malignant glioma	0.00102	0.00282	CbGeAlD
Asenapine—Insomnia—Carmustine—malignant glioma	0.00101	0.00718	CcSEcCtD
Asenapine—HTR1B—central nervous system—malignant glioma	0.001	0.00278	CbGeAlD
Asenapine—ADRA2A—telencephalon—malignant glioma	0.000998	0.00277	CbGeAlD
Asenapine—HTR1A—spinal cord—malignant glioma	0.000997	0.00276	CbGeAlD
Asenapine—Dyspnoea—Carmustine—malignant glioma	0.000996	0.00708	CcSEcCtD
Asenapine—Somnolence—Carmustine—malignant glioma	0.000993	0.00706	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000983	0.00699	CcSEcCtD
Asenapine—ADRA2C—medulla oblongata—malignant glioma	0.000983	0.00272	CbGeAlD
Asenapine—DRD1—brain—malignant glioma	0.000982	0.00272	CbGeAlD
Asenapine—HTR7—midbrain—malignant glioma	0.000977	0.00271	CbGeAlD
Asenapine—Insomnia—Temozolomide—malignant glioma	0.000976	0.00694	CcSEcCtD
Asenapine—HTR1D—central nervous system—malignant glioma	0.000971	0.00269	CbGeAlD
Asenapine—Gastrointestinal disorder—Carmustine—malignant glioma	0.000964	0.00686	CcSEcCtD
Asenapine—Dyspnoea—Temozolomide—malignant glioma	0.000962	0.00684	CcSEcCtD
Asenapine—HTR2C—central nervous system—malignant glioma	0.000961	0.00266	CbGeAlD
Asenapine—Somnolence—Temozolomide—malignant glioma	0.000959	0.00682	CcSEcCtD
Asenapine—HTR2A—brainstem—malignant glioma	0.000956	0.00265	CbGeAlD
Asenapine—Constipation—Carmustine—malignant glioma	0.000955	0.00679	CcSEcCtD
Asenapine—HTR7—spinal cord—malignant glioma	0.000953	0.00264	CbGeAlD
Asenapine—Dyspepsia—Temozolomide—malignant glioma	0.00095	0.00676	CcSEcCtD
Asenapine—ADRB1—central nervous system—malignant glioma	0.000943	0.00261	CbGeAlD
Asenapine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000932	0.00663	CcSEcCtD
Asenapine—Fatigue—Temozolomide—malignant glioma	0.00093	0.00662	CcSEcCtD
Asenapine—DRD2—midbrain—malignant glioma	0.000924	0.00256	CbGeAlD
Asenapine—Constipation—Temozolomide—malignant glioma	0.000923	0.00656	CcSEcCtD
Asenapine—HTR2A—retina—malignant glioma	0.000922	0.00256	CbGeAlD
Asenapine—SLC6A4—central nervous system—malignant glioma	0.000911	0.00253	CbGeAlD
Asenapine—HTR2B—central nervous system—malignant glioma	0.000903	0.0025	CbGeAlD
Asenapine—ADRA2C—midbrain—malignant glioma	0.000898	0.00249	CbGeAlD
Asenapine—ADRA2C—spinal cord—malignant glioma	0.000876	0.00243	CbGeAlD
Asenapine—CYP2D6—brainstem—malignant glioma	0.000871	0.00241	CbGeAlD
Asenapine—HTR2A—telencephalon—malignant glioma	0.000848	0.00235	CbGeAlD
Asenapine—Hypersensitivity—Carmustine—malignant glioma	0.000823	0.00585	CcSEcCtD
Asenapine—HTR1A—central nervous system—malignant glioma	0.000809	0.00224	CbGeAlD
Asenapine—Asthenia—Carmustine—malignant glioma	0.000801	0.0057	CcSEcCtD
Asenapine—HTR1B—brain—malignant glioma	0.000796	0.00221	CbGeAlD
Asenapine—Hypersensitivity—Temozolomide—malignant glioma	0.000795	0.00566	CcSEcCtD
Asenapine—HTR1A—cerebellum—malignant glioma	0.000791	0.00219	CbGeAlD
Asenapine—ADRA2A—medulla oblongata—malignant glioma	0.000784	0.00217	CbGeAlD
Asenapine—Asthenia—Temozolomide—malignant glioma	0.000774	0.00551	CcSEcCtD
Asenapine—HTR7—central nervous system—malignant glioma	0.000773	0.00214	CbGeAlD
Asenapine—CYP2D6—telencephalon—malignant glioma	0.000773	0.00214	CbGeAlD
Asenapine—HTR1D—brain—malignant glioma	0.000771	0.00214	CbGeAlD
Asenapine—HTR2C—brain—malignant glioma	0.000763	0.00212	CbGeAlD
Asenapine—HTR7—cerebellum—malignant glioma	0.000756	0.00209	CbGeAlD
Asenapine—ADRB1—brain—malignant glioma	0.000749	0.00208	CbGeAlD
Asenapine—ADRA1A—central nervous system—malignant glioma	0.000746	0.00207	CbGeAlD
Asenapine—Dizziness—Carmustine—malignant glioma	0.000738	0.00525	CcSEcCtD
Asenapine—DRD2—central nervous system—malignant glioma	0.000731	0.00203	CbGeAlD
Asenapine—ADRA1A—cerebellum—malignant glioma	0.000729	0.00202	CbGeAlD
Asenapine—SLC6A4—brain—malignant glioma	0.000724	0.00201	CbGeAlD
Asenapine—HTR2B—brain—malignant glioma	0.000717	0.00199	CbGeAlD
Asenapine—ADRA2A—midbrain—malignant glioma	0.000717	0.00199	CbGeAlD
Asenapine—DRD2—cerebellum—malignant glioma	0.000715	0.00198	CbGeAlD
Asenapine—Dizziness—Temozolomide—malignant glioma	0.000714	0.00508	CcSEcCtD
Asenapine—ADRA2C—central nervous system—malignant glioma	0.000711	0.00197	CbGeAlD
Asenapine—Vomiting—Carmustine—malignant glioma	0.00071	0.00505	CcSEcCtD
Asenapine—Rash—Carmustine—malignant glioma	0.000704	0.00501	CcSEcCtD
Asenapine—Dermatitis—Carmustine—malignant glioma	0.000703	0.005	CcSEcCtD
Asenapine—Headache—Carmustine—malignant glioma	0.0007	0.00498	CcSEcCtD
Asenapine—ADRA2A—spinal cord—malignant glioma	0.000699	0.00194	CbGeAlD
Asenapine—ADRA2C—cerebellum—malignant glioma	0.000695	0.00193	CbGeAlD
Asenapine—Vomiting—Temozolomide—malignant glioma	0.000686	0.00488	CcSEcCtD
Asenapine—Rash—Temozolomide—malignant glioma	0.00068	0.00484	CcSEcCtD
Asenapine—Dermatitis—Temozolomide—malignant glioma	0.00068	0.00484	CcSEcCtD
Asenapine—Headache—Temozolomide—malignant glioma	0.000676	0.00481	CcSEcCtD
Asenapine—HTR2A—medulla oblongata—malignant glioma	0.000667	0.00185	CbGeAlD
Asenapine—Nausea—Carmustine—malignant glioma	0.000663	0.00472	CcSEcCtD
Asenapine—HTR1A—brain—malignant glioma	0.000642	0.00178	CbGeAlD
Asenapine—Nausea—Temozolomide—malignant glioma	0.000641	0.00456	CcSEcCtD
Asenapine—HTR7—brain—malignant glioma	0.000614	0.0017	CbGeAlD
Asenapine—HTR2A—midbrain—malignant glioma	0.000609	0.00169	CbGeAlD
Asenapine—HTR2A—spinal cord—malignant glioma	0.000594	0.00165	CbGeAlD
Asenapine—ADRA1A—brain—malignant glioma	0.000592	0.00164	CbGeAlD
Asenapine—DRD2—brain—malignant glioma	0.00058	0.00161	CbGeAlD
Asenapine—HRH1—central nervous system—malignant glioma	0.000577	0.0016	CbGeAlD
Asenapine—ADRA2A—central nervous system—malignant glioma	0.000567	0.00157	CbGeAlD
Asenapine—ADRA2C—brain—malignant glioma	0.000564	0.00156	CbGeAlD
Asenapine—ADRA2A—cerebellum—malignant glioma	0.000554	0.00154	CbGeAlD
Asenapine—HTR2A—central nervous system—malignant glioma	0.000482	0.00134	CbGeAlD
Asenapine—HTR2A—cerebellum—malignant glioma	0.000471	0.00131	CbGeAlD
Asenapine—HRH1—brain—malignant glioma	0.000458	0.00127	CbGeAlD
Asenapine—ADRA2A—brain—malignant glioma	0.00045	0.00125	CbGeAlD
Asenapine—CYP3A4—central nervous system—malignant glioma	0.000446	0.00124	CbGeAlD
Asenapine—CYP2D6—central nervous system—malignant glioma	0.000439	0.00122	CbGeAlD
Asenapine—CYP2D6—cerebellum—malignant glioma	0.000429	0.00119	CbGeAlD
Asenapine—HTR2A—brain—malignant glioma	0.000383	0.00106	CbGeAlD
Asenapine—CYP2D6—brain—malignant glioma	0.000349	0.000967	CbGeAlD
Asenapine—DRD2—Signaling by GPCR—PIK3CA—malignant glioma	1.14e-05	4.37e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—PTEN—malignant glioma	1.14e-05	4.36e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—MDM2—malignant glioma	1.14e-05	4.35e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—PIK3CD—malignant glioma	1.14e-05	4.35e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—MMP9—malignant glioma	1.14e-05	4.34e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—RAF1—malignant glioma	1.14e-05	4.34e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—STAT3—malignant glioma	1.14e-05	4.33e-05	CbGpPWpGaD
Asenapine—ADRA2C—GPCR downstream signaling—AKT1—malignant glioma	1.13e-05	4.33e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—KRAS—malignant glioma	1.13e-05	4.32e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—VEGFA—malignant glioma	1.13e-05	4.32e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—KRAS—malignant glioma	1.13e-05	4.32e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—PTEN—malignant glioma	1.13e-05	4.32e-05	CbGpPWpGaD
Asenapine—ADRA2A—GPCR downstream signaling—PIK3CA—malignant glioma	1.13e-05	4.31e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—PIK3CA—malignant glioma	1.13e-05	4.3e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CASP3—malignant glioma	1.12e-05	4.29e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—ERBB2—malignant glioma	1.12e-05	4.29e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—PIK3CA—malignant glioma	1.12e-05	4.29e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—KRAS—malignant glioma	1.12e-05	4.29e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—MMP9—malignant glioma	1.12e-05	4.29e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—IL2—malignant glioma	1.12e-05	4.29e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—MDM2—malignant glioma	1.12e-05	4.28e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—STAT3—malignant glioma	1.12e-05	4.28e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—MDM2—malignant glioma	1.12e-05	4.27e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—MYC—malignant glioma	1.12e-05	4.27e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—RAF1—malignant glioma	1.12e-05	4.27e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—PTEN—malignant glioma	1.12e-05	4.26e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—RAF1—malignant glioma	1.12e-05	4.26e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—KRAS—malignant glioma	1.12e-05	4.26e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—AKT1—malignant glioma	1.11e-05	4.25e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—PIK3CB—malignant glioma	1.11e-05	4.23e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—CAV1—malignant glioma	1.11e-05	4.23e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—AKT1—malignant glioma	1.11e-05	4.23e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—ERBB2—malignant glioma	1.11e-05	4.22e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—ERBB2—malignant glioma	1.1e-05	4.21e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—AKT1—malignant glioma	1.1e-05	4.21e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—PIK3CA—malignant glioma	1.1e-05	4.21e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—KRAS—malignant glioma	1.1e-05	4.2e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—MDM2—malignant glioma	1.1e-05	4.19e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—MMP9—malignant glioma	1.1e-05	4.19e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—RAF1—malignant glioma	1.09e-05	4.18e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—EGFR—malignant glioma	1.09e-05	4.18e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—MMP9—malignant glioma	1.09e-05	4.17e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—PTEN—malignant glioma	1.09e-05	4.17e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—PIK3CB—malignant glioma	1.09e-05	4.17e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—FGF2—malignant glioma	1.09e-05	4.16e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—AKT1—malignant glioma	1.09e-05	4.16e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—PIK3CB—malignant glioma	1.09e-05	4.16e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—PTEN—malignant glioma	1.09e-05	4.15e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—ERBB2—malignant glioma	1.08e-05	4.13e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—KRAS—malignant glioma	1.08e-05	4.13e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—PIK3CB—malignant glioma	1.07e-05	4.08e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CXCL8—malignant glioma	1.07e-05	4.07e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—AKT1—malignant glioma	1.06e-05	4.06e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—MMP9—malignant glioma	1.06e-05	4.06e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—AKT1—malignant glioma	1.06e-05	4.04e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—PTEN—malignant glioma	1.06e-05	4.03e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—MYC—malignant glioma	1.05e-05	4.03e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CXCL8—malignant glioma	1.05e-05	4e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CXCL8—malignant glioma	1.05e-05	3.99e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—MYC—malignant glioma	1.04e-05	3.97e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—PIK3CA—malignant glioma	1.04e-05	3.97e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—PIK3CA—malignant glioma	1.04e-05	3.97e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—KRAS—malignant glioma	1.03e-05	3.95e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—PIK3CA—malignant glioma	1.03e-05	3.94e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—EGFR—malignant glioma	1.03e-05	3.94e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—VEGFA—malignant glioma	1.03e-05	3.93e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—AKT1—malignant glioma	1.03e-05	3.93e-05	CbGpPWpGaD
Asenapine—DRD2—GPCR downstream signaling—AKT1—malignant glioma	1.03e-05	3.93e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CXCL8—malignant glioma	1.03e-05	3.92e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—PTEN—malignant glioma	1.03e-05	3.92e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—PIK3CA—malignant glioma	1.02e-05	3.91e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—VEGFA—malignant glioma	1.02e-05	3.9e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—STAT3—malignant glioma	1.02e-05	3.9e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—MDM2—malignant glioma	1.02e-05	3.9e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CASP3—malignant glioma	1.02e-05	3.89e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IL2—malignant glioma	1.02e-05	3.89e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—EGFR—malignant glioma	1.02e-05	3.89e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—RAF1—malignant glioma	1.02e-05	3.88e-05	CbGpPWpGaD
Asenapine—HTR2A—GPCR downstream signaling—AKT1—malignant glioma	1.01e-05	3.87e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—STAT3—malignant glioma	1.01e-05	3.86e-05	CbGpPWpGaD
Asenapine—HRH1—GPCR downstream signaling—AKT1—malignant glioma	1.01e-05	3.86e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—PIK3CA—malignant glioma	1.01e-05	3.86e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PIK3CG—malignant glioma	1.01e-05	3.85e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—VEGFA—malignant glioma	1.01e-05	3.85e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—TP53—malignant glioma	1.01e-05	3.84e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—ERBB2—malignant glioma	1.01e-05	3.84e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—TP53—malignant glioma	1.01e-05	3.84e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CASP3—malignant glioma	1e-05	3.83e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IL2—malignant glioma	1e-05	3.83e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CASP3—malignant glioma	1e-05	3.82e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IL2—malignant glioma	1e-05	3.82e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—TP53—malignant glioma	9.99e-06	3.81e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—STAT3—malignant glioma	9.98e-06	3.81e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—PIK3CA—malignant glioma	9.95e-06	3.8e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—PIK3CB—malignant glioma	9.93e-06	3.79e-05	CbGpPWpGaD
Asenapine—ADRA1A—GPCR downstream signaling—AKT1—malignant glioma	9.92e-06	3.79e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—VEGFA—malignant glioma	9.86e-06	3.76e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CASP3—malignant glioma	9.83e-06	3.75e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IL2—malignant glioma	9.81e-06	3.75e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—VEGFA—malignant glioma	9.81e-06	3.74e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—TP53—malignant glioma	9.78e-06	3.73e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—STAT3—malignant glioma	9.76e-06	3.73e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—KRAS—malignant glioma	9.75e-06	3.72e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PPARG—malignant glioma	9.75e-06	3.72e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—STAT3—malignant glioma	9.71e-06	3.71e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GSTP1—malignant glioma	9.68e-06	3.69e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—MMP9—malignant glioma	9.64e-06	3.68e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—TP53—malignant glioma	9.62e-06	3.67e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—KRAS—malignant glioma	9.62e-06	3.67e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—PTEN—malignant glioma	9.58e-06	3.66e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CXCL8—malignant glioma	9.54e-06	3.64e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—VEGFA—malignant glioma	9.54e-06	3.64e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—PIK3CA—malignant glioma	9.5e-06	3.62e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—MMP9—malignant glioma	9.49e-06	3.62e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—MYC—malignant glioma	9.48e-06	3.62e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—MMP9—malignant glioma	9.47e-06	3.61e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—STAT3—malignant glioma	9.45e-06	3.61e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—PTEN—malignant glioma	9.43e-06	3.6e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CAT—malignant glioma	9.42e-06	3.59e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—PTEN—malignant glioma	9.41e-06	3.59e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—MYC—malignant glioma	9.4e-06	3.59e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—CAV1—malignant glioma	9.39e-06	3.58e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—AKT1—malignant glioma	9.35e-06	3.57e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—MMP9—malignant glioma	9.29e-06	3.55e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—MYC—malignant glioma	9.28e-06	3.54e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—EGFR—malignant glioma	9.28e-06	3.54e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—PTEN—malignant glioma	9.23e-06	3.52e-05	CbGpPWpGaD
Asenapine—ADRA2A—GPCR downstream signaling—AKT1—malignant glioma	9.22e-06	3.52e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—AKT1—malignant glioma	9.2e-06	3.51e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—EGFR—malignant glioma	9.19e-06	3.51e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—TP53—malignant glioma	9.19e-06	3.51e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—AKT1—malignant glioma	9.18e-06	3.5e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CASP3—malignant glioma	9.13e-06	3.49e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IL2—malignant glioma	9.12e-06	3.48e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—EGFR—malignant glioma	9.07e-06	3.46e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—MYC—malignant glioma	9.07e-06	3.46e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—MYC—malignant glioma	9.03e-06	3.44e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—AKT1—malignant glioma	9.01e-06	3.44e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.97e-06	3.42e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—PIK3CA—malignant glioma	8.96e-06	3.42e-05	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—PIK3CA—malignant glioma	8.91e-06	3.4e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—NCOR1—malignant glioma	8.89e-06	3.39e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PIK3CD—malignant glioma	8.88e-06	3.39e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—EGFR—malignant glioma	8.87e-06	3.39e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—PIK3CA—malignant glioma	8.84e-06	3.37e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—EGFR—malignant glioma	8.83e-06	3.37e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—MYC—malignant glioma	8.78e-06	3.35e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—KRAS—malignant glioma	8.76e-06	3.34e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—KRAS—malignant glioma	8.68e-06	3.31e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—TP53—malignant glioma	8.66e-06	3.31e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—VEGFA—malignant glioma	8.66e-06	3.3e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—MMP9—malignant glioma	8.63e-06	3.29e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—EGFR—malignant glioma	8.59e-06	3.28e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—PTEN—malignant glioma	8.58e-06	3.27e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—KRAS—malignant glioma	8.57e-06	3.27e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—STAT3—malignant glioma	8.57e-06	3.27e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PIK3CG—malignant glioma	8.55e-06	3.27e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—TP53—malignant glioma	8.55e-06	3.26e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—VEGFA—malignant glioma	8.52e-06	3.25e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—VEGFA—malignant glioma	8.5e-06	3.24e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—AKT1—malignant glioma	8.5e-06	3.24e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—AKT1—malignant glioma	8.49e-06	3.24e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—AKT1—malignant glioma	8.43e-06	3.22e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—STAT3—malignant glioma	8.43e-06	3.22e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—STAT3—malignant glioma	8.42e-06	3.21e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—KRAS—malignant glioma	8.38e-06	3.2e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—AKT1—malignant glioma	8.37e-06	3.19e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—VEGFA—malignant glioma	8.34e-06	3.18e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—KRAS—malignant glioma	8.34e-06	3.18e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—AKT1—malignant glioma	8.26e-06	3.15e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—STAT3—malignant glioma	8.26e-06	3.15e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PPARG—malignant glioma	8.26e-06	3.15e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—AKT1—malignant glioma	8.13e-06	3.1e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—KRAS—malignant glioma	8.11e-06	3.1e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—PIK3CA—malignant glioma	8.05e-06	3.07e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—PIK3CA—malignant glioma	7.98e-06	3.05e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—MYC—malignant glioma	7.96e-06	3.04e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—PIK3CA—malignant glioma	7.88e-06	3.01e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—MYC—malignant glioma	7.84e-06	2.99e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—MYC—malignant glioma	7.82e-06	2.98e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—EGFR—malignant glioma	7.79e-06	2.97e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—TP53—malignant glioma	7.79e-06	2.97e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—AKT1—malignant glioma	7.76e-06	2.96e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—VEGFA—malignant glioma	7.75e-06	2.96e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PIK3CB—malignant glioma	7.74e-06	2.95e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—TP53—malignant glioma	7.72e-06	2.95e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	7.7e-06	2.94e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—MYC—malignant glioma	7.67e-06	2.93e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—STAT3—malignant glioma	7.67e-06	2.93e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PTGS2—malignant glioma	7.67e-06	2.93e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—EGFR—malignant glioma	7.67e-06	2.93e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—PIK3CA—malignant glioma	7.66e-06	2.92e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—EGFR—malignant glioma	7.65e-06	2.92e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—TP53—malignant glioma	7.62e-06	2.91e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PIK3CD—malignant glioma	7.52e-06	2.87e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—EGFR—malignant glioma	7.51e-06	2.86e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—PIK3CA—malignant glioma	7.45e-06	2.84e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—TP53—malignant glioma	7.45e-06	2.84e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—TP53—malignant glioma	7.41e-06	2.83e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—KRAS—malignant glioma	7.36e-06	2.81e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—AKT1—malignant glioma	7.32e-06	2.79e-05	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—AKT1—malignant glioma	7.28e-06	2.78e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CAV1—malignant glioma	7.25e-06	2.77e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—KRAS—malignant glioma	7.24e-06	2.76e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—PIK3CA—malignant glioma	7.24e-06	2.76e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—KRAS—malignant glioma	7.23e-06	2.76e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—AKT1—malignant glioma	7.22e-06	2.76e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—TP53—malignant glioma	7.21e-06	2.75e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—MYC—malignant glioma	7.13e-06	2.72e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—KRAS—malignant glioma	7.09e-06	2.71e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—EGFR—malignant glioma	6.97e-06	2.66e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—PIK3CA—malignant glioma	6.76e-06	2.58e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PTEN—malignant glioma	6.69e-06	2.55e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—PIK3CA—malignant glioma	6.65e-06	2.54e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—PIK3CA—malignant glioma	6.64e-06	2.53e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PIK3CG—malignant glioma	6.6e-06	2.52e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—KRAS—malignant glioma	6.59e-06	2.51e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—AKT1—malignant glioma	6.58e-06	2.51e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PIK3CB—malignant glioma	6.55e-06	2.5e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—TP53—malignant glioma	6.54e-06	2.5e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—AKT1—malignant glioma	6.52e-06	2.49e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—PIK3CA—malignant glioma	6.51e-06	2.49e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PTGS2—malignant glioma	6.49e-06	2.48e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—TP53—malignant glioma	6.44e-06	2.46e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—AKT1—malignant glioma	6.43e-06	2.46e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—TP53—malignant glioma	6.42e-06	2.45e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PPARG—malignant glioma	6.37e-06	2.43e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—TP53—malignant glioma	6.3e-06	2.41e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—AKT1—malignant glioma	6.29e-06	2.4e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—AKT1—malignant glioma	6.26e-06	2.39e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—AKT1—malignant glioma	6.09e-06	2.32e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—PIK3CA—malignant glioma	6.05e-06	2.31e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—AKT1—malignant glioma	5.91e-06	2.26e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—TP53—malignant glioma	5.86e-06	2.24e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PIK3CD—malignant glioma	5.8e-06	2.22e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PTEN—malignant glioma	5.66e-06	2.16e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—AKT1—malignant glioma	5.52e-06	2.11e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—AKT1—malignant glioma	5.43e-06	2.07e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—AKT1—malignant glioma	5.42e-06	2.07e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—AKT1—malignant glioma	5.32e-06	2.03e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PIK3CB—malignant glioma	5.06e-06	1.93e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PTGS2—malignant glioma	5.01e-06	1.91e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—AKT1—malignant glioma	4.94e-06	1.89e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PIK3CA—malignant glioma	4.72e-06	1.8e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PTEN—malignant glioma	4.37e-06	1.67e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PIK3CA—malignant glioma	4e-06	1.53e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—AKT1—malignant glioma	3.85e-06	1.47e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—AKT1—malignant glioma	3.26e-06	1.25e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PIK3CA—malignant glioma	3.08e-06	1.18e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—AKT1—malignant glioma	2.52e-06	9.62e-06	CbGpPWpGaD
